|
|
|
|
|
|
|
M T Wed Th F |
|
8 July, 2026 |
|
|
sponsored by
|
|
|
|
Katalyze raises $10.5M as five of the top twenty global pharma companies run its agents in production
|
| Deviation and OOS investigations stall because the answers sit fragmented across Veeva, SAP, historians, and paper. Built with more than a hundred tenured scientists from companies including Sanofi, Pfizer, and Lilly, Katalyze grounds its agents in an Operational Data Layer, so every answer traces to a source, and deploys into existing GxP systems with no change to architecture. Customer teams have cut deviation investigations by 50%, lifted throughput 25%, and helped deliver more than 10 million doses to patients. |
|
|
|
|
|
|
|
|
|
|
|
|
|
Which private biotechs are making a big impact with cool science and bold leaders? We want to hear your nominees for our annual Endpoints 11 awards. You have another week to select a company, so fill out this form by July 15. |
|
|
|
Alex Hoffman |
Copy Chief and News Editor, Endpoints News
|
|
|
|
|
|
|
by Elizabeth Cairns
|
They say that the way to make money in a gold rush is to open a shop selling picks and shovels. By the same token... | |
|
|
|
|
|
|
|
|
by Ayisha Sharma
|
Two weeks after the European Commission launched an investigation into Sanofi, the French drugmaker has offered to stop making negative claims about a rival drugmaker's... | |
|
|
|
 |
|
|
|
by ENDPOINTS |
Plus news about Seres, Biocytogen, Whitehawk, Boehringer Ingelheim, Prime Vector and MindRank. ⚠️ Novartis reduces New Jersey headcount: A WARN noticefor the state notes... | |
|
|
|
|
|
|
by Elizabeth Cairns
|
Sino Biopharmaceutical announced drug development and sales pacts with two UK pharma companies on Wednesday. One will see the Hong Kong biotech licensean
investigational... | |
|
|
|
|
|
|
|
|
by Lei Lei Wu
|
Satellos Bioscience is building its case for a Duchenne muscular dystrophy pill with data in adult patients ahead of a potentially pivotal readout in children... | |
|
|
|
